| ARID1A mutations in endometriosis-associated ovarian carcinomas KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ... New England Journal of Medicine 363 (16), 1532-1543, 2010 | 1955 | 2010 |
| Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ... Cancer 123 (5), 802-813, 2017 | 789 | 2017 |
| Cancer-associated mutations in endometriosis without cancer MS Anglesio, N Papadopoulos, A Ayhan, TM Nazeran, M Noë, ... New England Journal of Medicine 376 (19), 1835-1848, 2017 | 613 | 2017 |
| Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ... New England Journal of Medicine 366 (3), 234-242, 2012 | 523 | 2012 |
| Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ... The Journal of pathology 231 (1), 21-34, 2013 | 504 | 2013 |
| Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013 | 475 | 2013 |
| Interfaces of malignant and immunologic clonal dynamics in ovarian cancer AW Zhang, A McPherson, K Milne, DR Kroeger, PT Hamilton, A Miranda, ... Cell 173 (7), 1755-1769. e22, 2018 | 324 | 2018 |
| Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species V Evdokimova, P Ruzanov, MS Anglesio, AV Sorokin, LP Ovchinnikov, ... Molecular and cellular biology 26 (1), 277-292, 2006 | 324 | 2006 |
| Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010 MS Anglesio, MS Carey, M Köbel, H MacKay, DG Huntsman Gynecologic oncology 121 (2), 407-415, 2011 | 308 | 2011 |
| Type-specific cell line models for type-specific ovarian cancer research MS Anglesio, KC Wiegand, N Melnyk, C Chow, C Salamanca, ... PloS one 8 (9), e72162, 2013 | 306 | 2013 |
| IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer MS Anglesio, J George, H Kulbe, M Friedlander, D Rischin, C Lemech, ... Clinical cancer research 17 (8), 2538-2548, 2011 | 269 | 2011 |
| Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes YK Wang, A Bashashati, MS Anglesio, DR Cochrane, DS Grewal, G Ha, ... Nature genetics 49 (6), 856-865, 2017 | 265 | 2017 |
| Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas MS Anglesio, S Kommoss, MC Tolcher, B Clarke, L Galletta, H Porter, ... The Journal of pathology 229 (1), 111-120, 2013 | 250 | 2013 |
| Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers Ĺ Helland, MS Anglesio, J George, PA Cowin, CN Johnstone, CM House, ... PloS one 6 (4), e18064, 2011 | 224 | 2011 |
| Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes SM Hunter, MS Anglesio, GL Ryland, R Sharma, YE Chiew, SM Rowley, ... Oncotarget 6 (35), 37663, 2015 | 219 | 2015 |
| The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers L Zhang, MS Anglesio, M O'Sullivan, F Zhang, G Yang, R Sarao, ... Nature medicine 13 (9), 1060-1069, 2007 | 182 | 2007 |
| Cancer‐associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse‐strand expression bias to predominantly mature 3p strands … MS Anglesio, Y Wang, W Yang, J Senz, A Wan, A Heravi‐Moussavi, ... The Journal of pathology 229 (3), 400-409, 2013 | 180 | 2013 |
| Synchronous endometrial and ovarian carcinomas: evidence of clonality MS Anglesio, YK Wang, M Maassen, HM Horlings, A Bashashati, J Senz, ... Journal of the National Cancer Institute 108 (6), djv428, 2016 | 175 | 2016 |
| Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden MS Anglesio, A Bashashati, YK Wang, J Senz, G Ha, W Yang, MR Aniba, ... The Journal of pathology 236 (2), 201-209, 2015 | 164 | 2015 |
| Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms R Mackenzie, S Kommoss, BJ Winterhoff, BR Kipp, JJ Garcia, J Voss, ... BMC cancer 15, 1-10, 2015 | 163 | 2015 |
Aline TalhoukUniversity of British ColumbiaVerified email at ubc.ca
